Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2019	Jun. 30, 2018
Current assets:
Cash	$ 149,169	$ 22,013
Prepaid expenses	4,164	7,474
Deposits and other receivables	1,000	1,000
Total current assets	154,333	30,487
Property and equipment, net (Note 3)	2,964	1,448
Total assets	157,297	31,935
Current liabilities:
Accounts payable and accrued expenses	672,507	719,633
Deferred compensation (Note 4)	844,122	421,641
Loan payable and accrued interest (Note 5)	9,228,213	9,028,983
Total current liabilities	10,777,742	10,201,657
Convertible notes payable - affiliates (Note 6)	3,619,099	3,525,216
Total liabilities	14,396,841	13,726,873
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 27,795,695 and 25,939,892 shares issued, respectively; 27,091,386 and 25,235,583 shares outstanding, respectively
Additional paid-in capital	109,853,840	108,117,330
Subscription receivable - affiliates (Note 7)	(504,650)	(174,650)
Accumulated deficit	(123,638,875)	(121,691,956)
Total Bion’s stockholders’ deficit	(14,289,685)	(13,749,276)
Noncontrolling interest	50,141	54,338
Total deficit	(14,239,544)	(13,694,938)
Total liabilities and deficit	157,297	31,935
Series B Preferred Stock [Member]
Current liabilities:
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $35,500 and $34,000, respectively (Note 7)	32,900	31,400
Series A Preferred Stock [Member]
Deficit:
Preferred stock
Series C Preferred Stock [Member]
Deficit:
Preferred stock